Skip to results
Modify your search
NARROW
1-20 of 25
Authors: Andrew M Donson
Sort by
Journal Article
Loss of LDOC1 by chromatin compaction in mesenchymal tumor cells is required for PFA1 ependymoma growth
Graziella Ribeiro de Sousa and others
Neuro-Oncology, noaf029, https://doi.org/10.1093/neuonc/noaf029
Published: 04 February 2025
Journal Article
BIOM-51. MOLECULAR SUBTYPES, CLINICAL CHARACTERISTICS, AND THERAPEUTIC IMPLICATIONS FOR CNS TUMORS WITHBCOR/BCORL1 FUSION/INTERNAL TANDEM DUPLICATION
Johannes Gojo and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii31, https://doi.org/10.1093/neuonc/noae165.0123
Published: 11 November 2024
Journal Article
ETMR-22. IDENTIFICATION OF 5-FLUROURACIL AS A SELECTIVE THERAPY IN A NOVEL EP300::BCOR FUSION GLIOMA TUMOR MODEL
Andrew M Donson and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.192
Published: 18 June 2024
Journal Article
EPEN-21. EXPLORATION OF TUMOR SUPPRESSOR LATS1 LOSS IN POSTERIOR FOSSA GROUP A EPENDYMOMA WITH LOSS OF CHROMOSOME 6Q
Andrew M Donson and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.223
Published: 18 June 2024
Journal Article
EPEN-23. TARGETING TRISOMY MDM4 INDUCES CELL DEATH IN 1Q+ PFA EPENDYMOMA THROUGH REACTIVATION OF THE P53 PATHWAY
Annaliese J Calzadilla and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.225
Published: 18 June 2024
Journal Article
EPEN-24. 5FU SENSITIVITY IS MEDIATED THROUGH TRISOMY UCK2 EXPRESSION IN 1Q+ PFA EPN
Andrea Marie Griesingr and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.226
Published: 18 June 2024
Journal Article
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis
Eric W Prince and others
Neuro-Oncology, Volume 26, Issue 6, June 2024, Pages 1109–1123, https://doi.org/10.1093/neuonc/noae015
Published: 09 February 2024
Journal Article
Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma
John DeSisto and others
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 538–552, https://doi.org/10.1093/neuonc/noad207
Published: 02 November 2023
Journal Article
Mapping pediatric brain tumors to their origins in the developing cerebellum
Konstantin Okonechnikov and others
Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1895–1909, https://doi.org/10.1093/neuonc/noad124
Published: 03 August 2023
Journal Article
Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study
Andrew M Donson and others
Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1854–1867, https://doi.org/10.1093/neuonc/noad096
Published: 29 May 2023
Journal Article
Spatial transcriptomic analysis delineates epithelial and mesenchymal subpopulations and transition stages in childhood ependymoma
Rui Fu and others
Neuro-Oncology, Volume 25, Issue 4, April 2023, Pages 786–798, https://doi.org/10.1093/neuonc/noac219
Published: 10 October 2022
Journal Article
EPEN-26. Chemokine receptor blockade reverses CCL2 mediated immunosuppression and restores CAR-T cell function in posterior fossa ependymoma
Allison P Cole and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i44, https://doi.org/10.1093/neuonc/noac079.162
Published: 03 June 2022
Journal Article
RARE-15. Astroblastoma, MN1 altered comprises two molecularly and clinically distinct subgroups defined by the fusion partners BEND2 and CXXC5
Felix Schmitt-Hoffner and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i12–i13, https://doi.org/10.1093/neuonc/noac079.040
Published: 03 June 2022
Journal Article
EDITOR'S CHOICE
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma
Kent A Riemondy and others
Neuro-Oncology, Volume 24, Issue 2, February 2022, Pages 273–286, https://doi.org/10.1093/neuonc/noab135
Published: 02 June 2021
Journal Article
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma
Angela M Pierce and others
Neuro-Oncology, Volume 21, Issue 12, December 2019, Pages 1540–1551, https://doi.org/10.1093/neuonc/noz116
Published: 03 September 2019
Journal Article
EPEN-09. RNA-SEQ ANALYSIS OF RECURRENT PAEDIATRIC EPENDYMOMAS REVEALS IMMUNOLOGICAL CHANGES SPECIFIC TO MOLECULAR SUBGROUPS
Timothy A Ritzmann and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i75, https://doi.org/10.1093/neuonc/noy059.210
Published: 22 June 2018
Journal Article
EPEN-10. ROLE OF DNA METHYLATION ANALYSIS IN RECURRENT PAEDIATRIC EPENDYMOMA
Hazel A Rogers and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i75, https://doi.org/10.1093/neuonc/noy059.211
Published: 22 June 2018
Journal Article
CRAN-11. MULTIPLEXED IMMUNOFLUORESCENCE REVEALS POTENTIAL PD-1/PD-L1 PATHWAY VULNERABILITIES IN CRANIOPHARYNGIOMA
Shannon Coy and others
Neuro-Oncology, Volume 20, Issue suppl_2, June 2018, Page i39, https://doi.org/10.1093/neuonc/noy059.048
Published: 22 June 2018
Journal Article
Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma
Shannon Coy and others
Neuro-Oncology, Volume 20, Issue 8, August 2018, Pages 1101–1112, https://doi.org/10.1093/neuonc/noy035
Published: 02 March 2018
Journal Article
EPND-03. RNA-SEQ GENE EXPRESSION ANALYSIS OF 106 FORMALIN-FIXED PARAFFIN-EMBEDDED PAEDIATRIC EPENDYMOMAS
Timothy Ritzmann and others
Neuro-Oncology, Volume 19, Issue suppl_4, June 2017, Page iv15, https://doi.org/10.1093/neuonc/nox083.061
Published: 31 May 2017
Advertisement
Advertisement